Skip to main content
Clinical Trials/CTRI/2013/03/003471
CTRI/2013/03/003471
Completed
N/A

Evaluation of Dermatological safety of investigational product by primary irritation patch test on health human volunteers of varied skin types - MSCR/ITCPT/2013-01

ITC RD Centre0 sites24 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
ITC RD Centre
Enrollment
24
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ITC RD Centre

Eligibility Criteria

Inclusion Criteria

  • Subjects age group 18 \- 55 years
  • Healthy male \& female volunteers
  • Subjects with skin type III to V.
  • Subjects willing to give a written informed consent.
  • Subjects willing to maintain the patch test in position for 24 hours
  • Subject has not participated in a similar investigation in the past two weeks.
  • Subjects willing to come for regular follow up.
  • Subjects ready to follow instructions during the study period.

Exclusion Criteria

  • Infection, allergy on the tested area
  • Skin allergy antecedents or atopic subjects
  • Hyper sensitivity to any component of the tested products
  • Athletes and subjects with history of excessive sweating
  • Cutaneous disease which may influence the study result
  • Chronic illness which may influence the cutaneous state.
  • Subjects on oral corticosteroid with dose 10mg/day
  • Subjects participating in any other cosmetic or therapeutic trial.
  • Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials